Publication
Article
Supplements and Featured Publications
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that has no established cure and is frequently fatal within 2 to 5 years as patients experience a rapid functional decline in their abilities to move, talk, swallow, and breathe. Current treatment options remain limited, but there is a pipeline of late-stage therapeutic options that could expand the treatment options for patients with ALS.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.